TBR

0.00%

$4.93 tribune resources limited

TBR offered to buy out NST stake in EKJV after 'insulting" offer, page-10

First 10 Last

Share
Profile

Follow
Schottenanger

3 Posts.

06/03/19

05:48

Post #: 37665120
Share

Originally posted by worzel1: ↑

I'm not sure how much you know about the background that has lead up to this, but the shares that were sold to EVN were owned by Rand before they were confiscated by ASIC and sold off. Rand is a subsidiary of TBR and the companies have the same board. The board has known about this for months and the proceeds of the sale obviously get paid to Rand. Therefore there is significant financial benefit to both companies if the TBR share price is maximised - ensuring the proceeds returned to Rand and TBR are also maximised. Billis' response that the offer from NST was insulting states that the price should be significantly above the NST offer, yet he allowed the sale to EVN to go thru at $3.73 effectively valuing the EKJV below the NST offer.......................A reasonable conclusion would be that what he has really done is INSULT every shareholder of TBR and RND by allowing this situation to evolve and then waiting until AFTER the sale to EVN to state how insulting the NST offer was.........So my questioning of the timing is really around the fact that this has cost shareholders(RND and TBR) about $20M if you add in the Philippines farce........so has he manipulated a bad situation to get EVN on the shareholder register to provide leverage against NST or he is he just incompetent??.............After all he could have "written a cheque" significantly below the current NST offer a few short years ago and already own the entirety of the EKJV.

Expand

"yet he allowed the sale to EVN to go thru at 3.75...." Most probably or certainly i am even not as familiar eastwest101 with the background - and wld like to get to know, how Mr. Billis managed that (allowed) to happen ? I was under the impression, that neither Tribune nor Rand had been in such position ? Thanks your kind feedback .

TBR Price at posting: $4.10 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

There are more pages in this discussion • 4 more messages in this thread...

First 10 Last

Add TBR (ASX) to my watchlist

(20min delay)
Last $4.93		Change 0.000(0.00%)		Mkt cap ! $230.8M

Open	High	Low	Value	Volume
$5.00	$5.00	$4.93	$8.398K	1.69K

Buyers (Bids)

No.	Vol.	Price($)
2	462	$4.93

Sellers (Offers)

Price($)	Vol.	No.
$5.00	4864	4

View Market Depth

No.	Vol.	Price($)
1	1100	4.850
1	2079	4.800
2	2250	4.600
1	538	4.500
1	550	4.310

Price($)	Vol.	No.
4.960	1	1
4.970	2	1
5.120	1000	1
5.200	200	1
5.500	100	1

Last trade - 16.10pm 22/11/2024 (20 minute delay)

TBR (ASX) Chart

TBR offered to buy out NST stake in EKJV after 'insulting" offer, page-10

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Sales growth pushes Lovisa's fortunes (and shares) upwards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

TBR offered to buy out NST stake in EKJV after 'insulting" offer, page-10

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Sales growth pushes Lovisa's fortunes (and shares) upwards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News